AbbVie posted higher fourth-quarter revenue on the back of growth from its immunology portfolio, led by arthritis and Crohn’s disease drugs Skyrizi and Rinvoq.
Source link
AbbVie Revenue Rises on Immunology Growth
Date:
More like thisRelated
39th annual Run for the Zoo is just a month away
ALBUQUERQUE, N.M. (KRQE) – The 39th annual Run for the...
How a No. 1 Hit With Kenny Chesney Changed Uncle Kracker’s Career
Kenny Chesney is well-known for his laid-back beach songs,...
A Grubhub Founder Wants to Change Your Flat Tire Now
Two roadside-assistance platforms merged last month and will be...